1Lombardi W L,Gilbert E M.Carvedilol in the failing heart.Clin Cardiol,2001,24:757—766.
2Sleiman O I, Murin J, Ghanem W M. Beta-blockers in heart failure. Bratisl Lek Listy,2001, 102: 332--337.
3Ball S G. Discontinuation of doxazosin arm of ALLHAT. Antihypertensive and lipid-lowering treatment to prevent heart attack. Lancet, 2000,355: 1558-- 1559.
4Cohn J N, Briston M R, Chien K R, et al. Report of the national heart , lung, and blood institute special emphasis panel on heart failure research. Circulation,1997,95:766--770.
5Ruffolo R R Jr, Feuerstein G Z. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. J Cardiovasc Pharmacol, 1998, 32 (Suppl 1): S22--S30.
6Communal C, Singh K, Pimentel D R, et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta- adrenergic pathway. Circulation,1998, 98: 1329--1334.
7Iwai-Kanai E, Hasegawa K, Araki M, et al. alpha-and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation,1999,100: 305--311.
8Fleck E, Harding S, Regitz Z. Heart Failure: Clinical aspects from basic reserch. Eur Heart J, 1994, 15(Suppl D) : 2--155.
